In addition to showing increased NK cells number with C3aR inhibition using FACS and IF, we also show that NK cell depletion abrogates the effect of the C3aR antagonist on tumor growth delay whereas the depletion of CD8+ T cells does not (Supplementary Fig. S7; Fig. 5E, right). The gene discussed is CD8A; the disease is neoplasm.